Galbut D L, Traad E A, Dorman M J, DeWitt P L, Larsen P B, Kurlansky P A, Carrillo R G, Gentsch T O, Ebra G
Miami Heart Institute, Fla.
J Thorac Cardiovasc Surg. 1993 Jul;106(1):128-35; discussion 135-6.
A surgical experience between October 1983 and December 1990, with 1467 consecutive patients 65 years of age and over, was used to compare patients receiving single internal mammary artery grafts (n = 736) with those receiving bilateral internal mammary artery grafts (n = 731). The mean age in the single-graft group was 73.2 years and 70.9 years in the bilateral-graft group (p < 0.001). Various clinical parameters were analyzed that revealed that the single-graft group had more women and more patients with unstable angina, a history of previous myocardial infarction, and emergency surgery (p < 0.05). There was no significant difference in cigarette smoking, hypertension, diabetes mellitus, hyperlipidemia, triple vessel coronary artery disease, left main coronary artery stenosis, or left ventricular function between the two groups. Hospital mortality for the single-graft group was 6.4% (47 patients) and 3.1% (23 patients) for the bilateral-graft group (p < 0.004). No significant difference was observed between the groups in the rate of reoperation for bleeding, sternal infection, respiratory failure, stroke, or perioperative infarction. Follow-up was obtained in 663 hospital survivors (96.4%) in the single-graft group and in 691 (97.7%) in the bilateral-graft group. Mean follow-up in the single-graft group was 42.5 months (range, 1 to 92.4 months) and 43.0 months (range, 1 to 90.3 months) in the bilateral-graft group. In the single-graft group, survival was 60.7% +/- 4.8% (+/- standard error of the mean) at 8 years (60 patients at risk); it was 67.9% +/- 8.1% (18 patients at risk) for the bilateral-graft group (p < 0.028). This comparative study demonstrates that bilateral internal mammary artery grafting can be accomplished in elderly patients with low operative risk and hospital morbidity. Moreover, patients in both groups had a reduction in cardiac events and significant functional improvement.
1983年10月至1990年12月期间,对1467例连续的65岁及以上患者进行了外科手术,将接受单支内乳动脉移植的患者(n = 736)与接受双侧内乳动脉移植的患者(n = 731)进行比较。单支移植组的平均年龄为73.2岁,双侧移植组为70.9岁(p < 0.001)。对各种临床参数进行分析后发现,单支移植组女性更多,不稳定型心绞痛、既往心肌梗死病史及急诊手术的患者更多(p < 0.05)。两组在吸烟、高血压、糖尿病、高脂血症、三支血管冠状动脉疾病、左主干冠状动脉狭窄或左心室功能方面无显著差异。单支移植组的医院死亡率为6.4%(47例患者),双侧移植组为3.1%(23例患者)(p < 0.004)。两组在出血、胸骨感染、呼吸衰竭、中风或围手术期梗死的再次手术率方面未观察到显著差异。单支移植组663例(96.4%)医院幸存者及双侧移植组691例(97.7%)获得了随访。单支移植组的平均随访时间为42.5个月(范围1至92.4个月),双侧移植组为43.0个月(范围1至90.3个月)。在单支移植组,8年时生存率为60.7%±4.8%(±平均标准误差)(60例有风险患者);双侧移植组为67.9%±8.1%(18例有风险患者)(p < 0.028)。这项比较研究表明,双侧内乳动脉移植可在手术风险低且医院发病率低的老年患者中完成。此外,两组患者的心脏事件均减少且功能有显著改善。